US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof
Patent 11753369 was granted and assigned to Ultragenyx Pharmaceutical on September, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
